A Novel Method of Screening for Ovarian Cancer Using Gynecologic Fluids and Mucus - clinical trial Phase II biomarker validation study Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Friday, February 08, 2013

A Novel Method of Screening for Ovarian Cancer Using Gynecologic Fluids and Mucus - clinical trial Phase II biomarker validation study



A Novel Method of Screening for Ovarian Cancer Using Gynecologic Fluids and Mucus

 Verified by: University of South Alabama, February 2013
First Received: February 6, 2013 | Last Updated: February 6, 2013

"There is a current belief that this cancer starts in the fallopian tubes and progresses towards the ovaries, spreading to the cells on the surface. Within the fallopian tubes and the uterus, there is a constant flow of mucus which has only one exit through the cervix and out the vagina. Proteins that are generated within the entire female reproductive system are trapped into this viscous fluid and eventually released as waste. When a routine PAP test is performed, a sample of this mucus is collected along with any cells, and preserved in the PAP fluid. The fluid is currently discarded but contains a protein profile showing of the status of the cells in the female reproductive system.....

0 comments :

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.